In an era of improved regulations to guarantee patient safety, clinical trials have become increasingly complex. As study sponsors now aim to meet multiple objectives and as the level of complexity grows, clinical supplies strategy should be supported by technology to facilitate the process at the site and depots. At the same time systems should offer more visibility across the supply chain, leading to better planning while maintaining regulatory compliance. With Direct-to-patient as a trend that will stay, systems need to have these built-in and become standard option going forward.
mIRT optimizes clinical trial supply management practices to help position your trials towards success.